查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1462690

电阻分析仪的全球市场预测（截至 2030 年）：按产品类型、模式、使用类型、应用、最终用户和地区进行分析

Bioimpedance Analyzers Market Forecasts to 2030 - Global Analysis By Product Type (Single-frequency, Dual-frequency and Multi-frequency), By Modality (Wired and Wireless), Usage Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

2023年全球生物阻抗电阻市场规模为5.305亿美元，预计到2030年将达到10.877亿美元，预测期内复合年增长率为10.8%。生物阻抗电阻是一种测量活体组织电电阻的装置。

透过使微电流通过身体并测量产生的电压，它可以估计身体组成参数，例如脂肪量、去脂体重和总水分。它通常用于医疗保健、健身和研究环境中，以评估水合状态并监测身体组成随时间的变化。

根据国际糖尿病联盟（IDF）2021年发布的资料，2021年全球整体20岁至79岁的糖尿病患者人数将达5.37亿人。

慢性疾病和肥胖的增加

生物阻抗电阻对于评估脂肪量、肌肉量和水合程度等身体组成至关重要，这些都是健康状况和疾病风险的重要指标。随着糖尿病、心血管疾病和与肥胖相关的代谢紊乱等慢性疾病在全球范围内的增加，对生物阻抗电阻等有助于早期检测、监测和管理的工具的需求不断增长，从而推动市场份额的增长。

生物阻抗电阻高成本

先进生物阻抗电阻的高成本是电阻分析仪市场的主要限制。这些具有先进功能和性能的先进设备通常价格昂贵，限制了某些人群和医疗机构的使用。此外，购买和维护这些分析仪所需的初始投资可能会降低潜在的购买意愿，尤其是在资源有限的环境中。

家庭医疗保健中越来越多地采用生物阻抗电阻

这些设备为使用者提供了在舒适的家中监测身体组成和健康参数的便利，使个人能够采取积极主动的措施来更好地管理自己的健康。随着远端医疗和远端患者监护的兴起，生物阻抗电阻可以促进及时干预和个人化护理计划。此外，可携式和用户友好型设计的进步将提高可访问性，并鼓励寻求便捷健康监测解决方案的消费者广泛采用。

与替代身体组成分析方法的竞争

双能量X射线检测法（DEXA）和空气置换体积描记法（ADP）比电阻分析更准确和准确。儘管生物阻抗电阻方便且非侵入性，但有时在临床和研究环境中它们被认为不太准确。这种竞争对市场成长提出了挑战，有可能将需求转向更成熟、更可靠的技术，特别是在准确的身体组成测量至关重要的应用中，例如医疗诊断和运动表现分析。

COVID-19 的影响：

COVID-19 的爆发对生物阻抗电阻市场既有正面的影响，也有负面的影响。儘管疫情提高了人们对健康监测和健身的认识，但製造、供应链和医疗保健服务的中断阻碍了市场的成长。然而，随着医疗保健系统的復苏以及大流行后预防性护理和远端患者监护的重新关注，市场预计将復苏。

预计身体测量部分在预测期内将是最大的

在预测期内，生物阻抗电阻市场预计将由身体部位测量领域主导。这主要是由于人们越来越重视个人健身和医疗保健，以及对精确身体组成分析的需求不断增加。此外，技术进步促进了生物阻抗电阻的发展，可以准确测量不同部位的身体成分，从而可以在体重管理、优化运动表现和疾病预防等领域进行有针对性的干预。

预计多频细分市场在预测期内复合年增长率最高

预计在预测期内，生物阻抗电阻市场的多频部分将呈现显着成长。这是由于越来越多地采用多频生物阻抗电阻，提高了身体组成测量的准确性和可靠性。这些分析仪透过评估体内的各种组织和液体室来提供更全面的资料，满足医疗保健、健身和研究应用中对先进和精确的身体组成分析不断增长的需求。

占比最大的地区：

北美预计将保持其在生物阻抗电阻市场的主导地位。这主要得益于发达的医疗基础设施、先进医疗技术的高采用率以及预防性医疗措施意识增强等因素。此外，持续的研发活动和政府积极促进医疗创新预计将进一步推动该地区的市场成长，并巩固北美在生物阻抗电阻市场的主导地位。

复合年增长率最高的地区：

亚太地区是生物阻抗电阻市场成长最快的地区。慢性病的增加、医疗保健支出的增加以及预防性医疗保健措施意识的增强等因素正在推动该地区的市场扩张。此外，医疗基础设施的改善、技术的进步和庞大的人口也促进了生物阻抗电阻需求的快速成长。由于这些因素，亚太地区拥有显着的成长机会，并在全球生物阻抗电阻市场中占据重要地位。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球生物阻抗电阻市场：依产品类型

  • 单频
  • 双频
  • 多频

第六章全球生物阻抗电阻市场：按模式

  • 有线
  • 无线的

第七章全球生物阻抗电阻市场：依使用类型

  • 消费级
  • 专业级

第八章全球生物阻抗电阻市场：依应用

  • 生物回馈疗法和训练
  • 身体水分监测
  • 健身和健美
  • 医学诊断
  • 营养评估
  • 依身体部位测量身体尺寸
  • 全身身体组成测量

第九章全球生物阻抗电阻市场：依最终用户分类

  • 健身中心和健身房
  • 家庭用户
  • 医院和诊所
  • 职业运动员和教练
  • 研究机构

第十章全球生物阻抗电阻市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第十一章 主要进展

  • 协议、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Akern Srl
  • Analog Devices
  • BIOSPACE Co., Ltd.
  • Bodystat Ltd.
  • Charder Electronic Co., Ltd.
  • ImpediMed Limited
  • InBody Co., Ltd.
  • LAICA SpA
  • Maltron International Ltd.
  • Medical Electronic Construction
  • Omron Healthcare, Inc.
  • RJL Systems, Inc.
  • seca GmbH & Co. KG
  • SELVAS Healthcare, Inc.
  • Spectra Medical Devices, Inc.
  • Tanita Corporation
  • Valhalla Scientific, Inc.
  • Xiaomi
  • Xitron Technologies
Product Code: SMRC25741

According to Stratistics MRC, the Global Bioimpedance Analyzers Market is accounted for $530.5 million in 2023 and is expected to reach $1087.7 million by 2030 growing at a CAGR of 10.8% during the forecast period. Bioimpedance analyzers are devices used to measure the electrical impedance of biological tissues. By applying a small electrical current to the body and measuring the resulting voltage, these analyzers estimate body composition parameters such as fat mass, lean body mass, and total body water. They are commonly used in healthcare, fitness, and research settings to assess hydration status and monitor changes in body composition over time.

According to the International Diabetes Federation (IDF) data published in 2021, globally, there were 537 million people years affected by diabetes aged between 20 to79 in 2021.

Market Dynamics:

Driver:

Increasing prevalence of chronic diseases and obesity

Bioimpedance analyzers are pivotal in assessing body composition, including fat mass, muscle mass, and hydration levels, which are critical indicators of health and disease risk. With the global rise in chronic conditions such as diabetes, cardiovascular diseases, and metabolic disorders linked to obesity, there is a growing demand for tools like bioimpedance analyzers to facilitate early detection, monitoring, and management, driving market growth.

Restraint:

High cost associated with advanced bioimpedance analyzers

The high cost associated with advanced bioimpedance analyzers represents a significant restraint in the bioimpedance analyzers market. These sophisticated devices, equipped with advanced features and capabilities, often come with a hefty price tag, limiting their accessibility to certain demographic segments and healthcare facilities. Additionally, the initial investment required for purchasing and maintaining these analyzers may deter potential buyers, especially in resource-constrained settings.

Opportunity:

Increasing adoption of bioimpedance analyzers in home healthcare settings

These devices offer users the convenience of monitoring their body composition and health parameters from the comfort of their homes, empowering individuals to take proactive measures towards better health management. With the rise of telemedicine and remote patient monitoring, bioimpedance analyzers can facilitate timely interventions and personalized care plans. Additionally, advancements in portable and user-friendly designs enhance accessibility and encourage broader adoption among consumers seeking convenient health monitoring solutions.

Threat:

Competition from alternative body composition analysis methods

Methods like dual-energy X-ray absorptiometry (DEXA) and air displacement plethysmography (ADP) offer higher precision and accuracy compared to bioimpedance analysis. While bioimpedance analyzers are convenient and non-invasive, their accuracy may be perceived as inferior in clinical and research settings. This competition challenges the market's growth by potentially diverting demand towards more established and trusted techniques, especially in applications where precise body composition measurements are critical, such as medical diagnosis and sports performance analysis.

Covid-19 Impact:

The COVID-19 pandemic has both positively and negatively impacted the bioimpedance analyzers market. While there has been increased awareness of health monitoring and fitness due to the pandemic, disruptions in manufacturing, supply chains, and healthcare services have hindered market growth. However, the market is expected to rebound as healthcare systems recover, and there is a renewed focus on preventive healthcare and remote patient monitoring post-pandemic.

The segmental body measurement segment is expected to be the largest during the forecast period

The segmental body measurement segment is anticipated to dominate the bioimpedance analyzer market throughout the forecast period. This is primarily attributed to the growing emphasis on personalized fitness and healthcare, driving the demand for precise body composition analysis. Additionally, advancements in technology have led to the development of bioimpedance analyzers capable of accurately measuring segmental body composition, allowing for targeted interventions in areas such as weight management, sports performance optimization, and disease prevention.

The multi-frequency segment is expected to have the highest CAGR during the forecast period

The multi-frequency segment is poised to exhibit significant growth in the bioimpedance analyzers market during the forecast period. This is attributed to the increasing adoption of multi-frequency bioimpedance analyzers, which offer enhanced accuracy and reliability in measuring body composition. These analyzers provide more comprehensive data by assessing various tissues and fluid compartments within the body, thus catering to the increasing demand for advanced and precise body composition analysis in healthcare, fitness, and research applications.

Region with largest share:

North America is poised to maintain its dominance in the bioimpedance analyzers market. This is primarily due to factors such as the presence of well-established healthcare infrastructure, high adoption rates of advanced medical technologies, and increasing awareness regarding preventive healthcare measures. Additionally, ongoing research and development activities, coupled with favorable government initiatives to promote healthcare innovations, are expected to further drive market growth in the region, solidifying North America's leading position in the bioimpedance analyzers market.

Region with highest CAGR:

Asia Pacific is positioned for rapid growth in the bioimpedance analyzers market. Factors such as the increasing prevalence of chronic diseases, rising healthcare expenditure, and growing awareness about preventive healthcare measures are driving market expansion in the region. Additionally, improving healthcare infrastructure, technological advancements, and a large population base contribute to the burgeoning demand for bioimpedance analyzers. These factors collectively propel Asia Pacific towards significant growth opportunities and a prominent position in the global bioimpedance analyzers market.

Key players in the market

Some of the key players in Bioimpedance Analyzers Market include Akern Srl, Analog Devices, BIOSPACE Co., Ltd., Bodystat Ltd., Charder Electronic Co., Ltd., ImpediMed Limited, InBody Co., Ltd., LAICA S.p.A., Maltron International Ltd., Medical Electronic Construction, Omron Healthcare, Inc., RJL Systems, Inc., seca GmbH & Co. KG, SELVAS Healthcare, Inc., Spectra Medical Devices, Inc., Tanita Corporation, Valhalla Scientific, Inc., Xiaomi and Xitron Technologies.

Key Developments:

In September 2022, Xiaomi launched an eight-electrode body composition scale that provides up to 35 body composition analysis reports. This body fat scale adopts a dual-frequency bioimpedance measurement technology to provide accurate measurements.

In April 2022, InBody, a worldwide leader in body composition technology, is pleased to announce the release of its BWA 2.0 body water analyzer. This new professional-grade device expands upon the outputs measured by the InBody S10 to provide users with more detailed insights that demonstrate how variations in body composition and body water can affect wellbeing.

In March 2022, Analog Devices launched a low-power, high-performance analog front end built for wearable bioimpedance monitoring, MAX30009. This device promised clinical-grade vital sign measurement for patient assessment.

Product Types Covered:

  • Single-frequency
  • Dual-frequency
  • Multi-frequency

Modalities Covered:

  • Wired
  • Wireless

Usage Types Covered:

  • Consumer-grade
  • Professional-grade

Application Covered:

  • Biofeedback and Training
  • Body Hydration Monitoring
  • Fitness and Bodybuilding
  • Medical Diagnosis
  • Nutritional Assessment
  • Segmental Body Measurement
  • Whole Body Composition Measurement

End Users Covered:

  • Fitness Centers and Gyms
  • Home Users
  • Hospitals and Clinics
  • Professional Athletes and Trainers
  • Research Institutions

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bioimpedance Analyzers Market, By Product Type

  • 5.1 Introduction
  • 5.2 Single-frequency
  • 5.3 Dual-frequency
  • 5.4 Multi-frequency

6 Global Bioimpedance Analyzers Market, By Modality

  • 6.1 Introduction
  • 6.2 Wired
  • 6.3 Wireless

7 Global Bioimpedance Analyzers Market, By Usage Type

  • 7.1 Introduction
  • 7.2 Consumer-grade
  • 7.3 Professional-grade

8 Global Bioimpedance Analyzers Market, By Application

  • 8.1 Introduction
  • 8.2 Biofeedback and Training
  • 8.3 Body Hydration Monitoring
  • 8.4 Fitness and Bodybuilding
  • 8.5 Medical Diagnosis
  • 8.6 Nutritional Assessment
  • 8.7 Segmental Body Measurement
  • 8.8 Whole Body Composition Measurement

9 Global Bioimpedance Analyzers Market, By End User

  • 9.1 Introduction
  • 9.2 Fitness Centers and Gyms
  • 9.3 Home Users
  • 9.4 Hospitals and Clinics
  • 9.5 Professional Athletes and Trainers
  • 9.6 Research Institutions

10 Global Bioimpedance Analyzers Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Akern Srl
  • 12.2 Analog Devices
  • 12.3 BIOSPACE Co., Ltd.
  • 12.4 Bodystat Ltd.
  • 12.5 Charder Electronic Co., Ltd.
  • 12.6 ImpediMed Limited
  • 12.7 InBody Co., Ltd.
  • 12.8 LAICA S.p.A.
  • 12.9 Maltron International Ltd.
  • 12.10 Medical Electronic Construction
  • 12.11 Omron Healthcare, Inc.
  • 12.12 RJL Systems, Inc.
  • 12.13 seca GmbH & Co. KG
  • 12.14 SELVAS Healthcare, Inc.
  • 12.15 Spectra Medical Devices, Inc.
  • 12.16 Tanita Corporation
  • 12.17 Valhalla Scientific, Inc.
  • 12.18 Xiaomi
  • 12.19 Xitron Technologies

List of Tables

  • Table 1 Global Bioimpedance Analyzers Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Bioimpedance Analyzers Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Bioimpedance Analyzers Market Outlook, By Single-frequency (2021-2030) ($MN)
  • Table 4 Global Bioimpedance Analyzers Market Outlook, By Dual-frequency (2021-2030) ($MN)
  • Table 5 Global Bioimpedance Analyzers Market Outlook, By Multi-frequency (2021-2030) ($MN)
  • Table 6 Global Bioimpedance Analyzers Market Outlook, By Modality (2021-2030) ($MN)
  • Table 7 Global Bioimpedance Analyzers Market Outlook, By Wired (2021-2030) ($MN)
  • Table 8 Global Bioimpedance Analyzers Market Outlook, By Wireless (2021-2030) ($MN)
  • Table 9 Global Bioimpedance Analyzers Market Outlook, By Usage Type (2021-2030) ($MN)
  • Table 10 Global Bioimpedance Analyzers Market Outlook, By Consumer-grade (2021-2030) ($MN)
  • Table 11 Global Bioimpedance Analyzers Market Outlook, By Professional-grade (2021-2030) ($MN)
  • Table 12 Global Bioimpedance Analyzers Market Outlook, By Application (2021-2030) ($MN)
  • Table 13 Global Bioimpedance Analyzers Market Outlook, By Biofeedback and Training (2021-2030) ($MN)
  • Table 14 Global Bioimpedance Analyzers Market Outlook, By Body Hydration Monitoring (2021-2030) ($MN)
  • Table 15 Global Bioimpedance Analyzers Market Outlook, By Fitness and Bodybuilding (2021-2030) ($MN)
  • Table 16 Global Bioimpedance Analyzers Market Outlook, By Medical Diagnosis (2021-2030) ($MN)
  • Table 17 Global Bioimpedance Analyzers Market Outlook, By Nutritional Assessment (2021-2030) ($MN)
  • Table 18 Global Bioimpedance Analyzers Market Outlook, By Segmental Body Measurement (2021-2030) ($MN)
  • Table 19 Global Bioimpedance Analyzers Market Outlook, By Whole Body Composition Measurement (2021-2030) ($MN)
  • Table 20 Global Bioimpedance Analyzers Market Outlook, By End User (2021-2030) ($MN)
  • Table 21 Global Bioimpedance Analyzers Market Outlook, By Fitness Centers and Gyms (2021-2030) ($MN)
  • Table 22 Global Bioimpedance Analyzers Market Outlook, By Home Users (2021-2030) ($MN)
  • Table 23 Global Bioimpedance Analyzers Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
  • Table 24 Global Bioimpedance Analyzers Market Outlook, By Professional Athletes and Trainers (2021-2030) ($MN)
  • Table 25 Global Bioimpedance Analyzers Market Outlook, By Research Institutions (2021-2030) ($MN)
  • Table 26 Global Bioimpedance Analyzers Market Outlook, By Other Applications (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.